Themis Medicare (NSE:THEMISMED) YoY EBITDA Growth : 18.73% (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Themis Medicare YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Themis Medicare's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 18.73%.

Themis Medicare's EBITDA per Share for the three months ended in Sep. 2024 was ₹2.46.

Themis Medicare YoY EBITDA Growth Historical Data

The historical data trend for Themis Medicare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Themis Medicare YoY EBITDA Growth Chart

Themis Medicare Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

695.89

31.61

82.37

-18.23

-19.46

Themis Medicare Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															-30.73	-37.27	-14.25	29.12	18.73

Themis Medicare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Themis Medicare's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(7.951	-	9.872)	/	\| 9.872 \|
=	-19.46 %

Themis Medicare's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(2.46	-	2.072)	/	\| 2.072 \|
=	18.73 %

Themis Medicare YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Themis Medicare's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Themis Medicare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Themis Medicare Ltd (NSE:THEMISMED) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

530199:India

Address

Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104

Website

https://www.themismedicare.com

Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.

Themis Medicare Headlines

No Headlines